Literature DB >> 2069850

Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy.

R M Dixon1, P W Angus, B Rajagopalan, G K Radda.   

Abstract

Hepatic infiltration by lymphoma can be difficult to detect by conventional methods. We have studied 22 patients in vivo 31P magnetic resonance spectroscopy of the liver and compared the results with the clinical staging and assessment of liver involvement by computed tomography (CT), ultrasound (US), and liver function tests (LFTs). We find that the phosphomonoester (PME) to ATP, and the PME to Pi ratios are the best indication of liver involvement as in all the patients with liver involvement apparent on CT or US, these ratios were elevated (greater than 2 s.d. above the control mean). Of the patients with deranged LFTs but normal CT or US, five out of nine showed increased PME/ATP and PME/Pi ratios, and in the patients with normal LFTs and normal CT or US, three out of eight patients had raised PME ratios. Extracts of lymphomatous lymph nodes contain high concentrations of phosphoethanolamine which suggests that this compound is responsible for the increase in the PME peak. Eleven patients were studied again after chemotherapy, and those with initially raised PME/ATP and PME/Pi ratios all showed a decrease in these ratios towards normal. The patients with initially normal ratios showed no changes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069850      PMCID: PMC1972561          DOI: 10.1038/bjc.1991.208

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

Review 1.  Use of imaging in the management of lymphoma.

Authors:  S J Golding
Journal:  Br J Hosp Med       Date:  1989-02

2.  In-vivo 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer.

Authors:  J Glaholm; M O Leach; D J Collins; J Mansi; J C Sharp; A Madden; I E Smith; V R McCready
Journal:  Lancet       Date:  1989-06-10       Impact factor: 79.321

3.  Phosphate metabolites in lymphoid, Friend erythroleukemia, and HeLa cells observed by high-resolution 31P nuclear magnetic resonance.

Authors:  G Navon; R Navon; R G Shulman; T Yamane
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

4.  Therapeutic response of breast carcinoma monitored by 31P MRS in situ.

Authors:  T C Ng; S Grundfest; S Vijayakumar; N J Baldwin; A W Majors; I Karalis; T F Meaney; K H Shin; F J Thomas; R Tubbs
Journal:  Magn Reson Med       Date:  1989-04       Impact factor: 4.668

5.  The use of the chemical shift of the phosphomonoester P-31 magnetic resonance peak for the determination of intracellular pH in the brains of neonates.

Authors:  R J Corbett; A R Laptook; R L Nunnally
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

6.  Study of human liver disease with P-31 magnetic resonance spectroscopy.

Authors:  R Oberhaensli; B Rajagopalan; G J Galloway; D J Taylor; G K Radda
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

7.  EORTC trial non-Hodgkin lymphomas.

Authors:  R Somers; J M Burgers; M Qasim; M Van Glabbeke; N Duez; M Hayat
Journal:  Eur J Cancer Clin Oncol       Date:  1987-03

8.  Phosphatidylcholine biosynthesis in cultured glioma cells: evidence for channeling of intermediates.

Authors:  T P George; S C Morash; H W Cook; D M Byers; F B Palmer; M W Spence
Journal:  Biochim Biophys Acta       Date:  1989-08-22

9.  Phosphorus-31 nuclear magnetic resonance spectroscopy of human retinoblastoma cells: correlation with metabolic indices.

Authors:  M V Miceli; L S Kan; D A Newsome
Journal:  Biochim Biophys Acta       Date:  1988-07-29

10.  31P-NMR spectroscopy of human cancer cells proliferating in a basement membrane gel.

Authors:  P F Daly; R C Lyon; E J Straka; J S Cohen
Journal:  FASEB J       Date:  1988-07       Impact factor: 5.191

View more
  10 in total

1.  Metabolic control patterns in acute phase and regenerating human liver determined in vivo by 31-phosphorus magnetic resonance spectroscopy.

Authors:  Darren V Mann; Wynnie W M Lam; N Magnus Hjelm; Nina M C So; David K W Yeung; Constantine Metreweli; Wan Y Lau
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

Review 2.  In vivo magnetic resonance spectroscopy of liver tumors and metastases.

Authors:  E G W ter Voert; L Heijmen; H W M van Laarhoven; A Heerschap
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

3.  Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.

Authors:  Bengt Norén; Peter Lundberg; Marcus Ressner; Staffan Wirell; Sven Almer; Orjan Smedby
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

4.  Phosphatidylethanolamine metabolism in rat liver after partial hepatectomy. Control of biosynthesis of phosphatidylethanolamine by the availability of ethanolamine.

Authors:  M Houweling; L B Tijburg; W J Vaartjes; L M van Golde
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

5.  Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.

Authors:  D J Propper; N C Levitt; K O'Byrne; J P Braybrooke; D C Talbot; T S Ganesan; C H Thompson; B Rajagopalan; T J Littlewood; R M Dixon; A L Harris
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

Review 6.  Targeting Phospholipid Metabolism in Cancer.

Authors:  Menglin Cheng; Zaver M Bhujwalla; Kristine Glunde
Journal:  Front Oncol       Date:  2016-12-27       Impact factor: 6.244

Review 7.  In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.

Authors:  Ladislav Valkovič; Marek Chmelík; Martin Krššák
Journal:  Anal Biochem       Date:  2017-01-21       Impact factor: 3.365

8.  Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro.

Authors:  C P Thomas; R M Dixon; M Tian; S A Butler; C J Counsell; J K Bradley; G E Adams; G K Radda
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

9.  Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study.

Authors:  R Kalra; K E Wade; L Hands; P Styles; R Camplejohn; M Greenall; G E Adams; A L Harris; G K Radda
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using 31 P MRSI and Hepatic Lipid Volume Correction at 7T Suggests No Dependence on Body Mass Index or Age.

Authors:  Lorenz Pfleger; Martin Gajdošík; Peter Wolf; Sabina Smajis; Paul Fellinger; Andre Kuehne; Patrik Krumpolec; Siegfried Trattnig; Yvonne Winhofer; Michael Krebs; Martin Krššák; Marek Chmelík
Journal:  J Magn Reson Imaging       Date:  2018-10-06       Impact factor: 4.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.